Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Operating Income 2011-2025 | UTHR

United Therapeutics annual/quarterly operating income history and growth rate from 2011 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • United Therapeutics operating income for the quarter ending September 30, 2025 was $0.389B, a 13.23% increase year-over-year.
  • United Therapeutics operating income for the twelve months ending September 30, 2025 was $1.494B, a 16.73% increase year-over-year.
  • United Therapeutics annual operating income for 2024 was $1.377B, a 16.21% increase from 2023.
  • United Therapeutics annual operating income for 2023 was $1.185B, a 20.95% increase from 2022.
  • United Therapeutics annual operating income for 2022 was $0.98B, a 76.24% increase from 2021.
United Therapeutics Annual Operating Income
(Millions of US $)
2024 $1,377
2023 $1,185
2022 $980
2021 $556
2020 $594
2019 $-188
2018 $805
2017 $815
2016 $1,062
2015 $699
2014 $539
2013 $292
2012 $422
2011 $318
2010 $171
United Therapeutics Quarterly Operating Income
(Millions of US $)
2025-09-30 $389
2025-06-30 $365
2025-03-31 $383
2024-12-31 $358
2024-09-30 $343
2024-06-30 $320
2024-03-31 $356
2023-12-31 $260
2023-09-30 $327
2023-06-30 $313
2023-03-31 $284
2022-12-31 $176
2022-09-30 $314
2022-06-30 $202
2022-03-31 $288
2021-12-31 $170
2021-09-30 $229
2021-06-30 $222
2021-03-31 $-65
2020-12-31 $65
2020-09-30 $221
2020-06-30 $141
2020-03-31 $167
2019-12-31 $64
2019-09-30 $183
2019-06-30 $221
2019-03-31 $-656
2018-12-31 $132
2018-09-30 $150
2018-06-30 $217
2018-03-31 $307
2017-12-31 $139
2017-09-30 $324
2017-06-30 $89
2017-03-31 $264
2016-12-31 $174
2016-09-30 $239
2016-06-30 $285
2016-03-31 $364
2015-12-31 $155
2015-09-30 $387
2015-06-30 $172
2015-03-31 $-15
2014-12-31 $179
2014-09-30 $-32
2014-06-30 $176
2014-03-31 $216
2013-12-31 $-28
2013-09-30 $105
2013-06-30 $122
2013-03-31 $94
2012-12-31 $129
2012-09-30 $81
2012-06-30 $106
2012-03-31 $107
2011-12-31 $64
2011-09-30 $103
2011-06-30 $114
2011-03-31 $37
2010-12-31 $15
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.545B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $78.129B 29.67
Zoetis (ZTS) United States $52.791B 18.89
Takeda Pharmaceutical (TAK) Japan $43.625B 8.90
Daiichi Sankyo, - (DSNKY) Japan $40.634B 20.24
BeOne Medicines - (ONC) Switzerland $36.101B 191.40
Sandoz Group AG (SDZNY) Switzerland $29.630B 0.00
Merck (MKKGY) Germany $16.472B 10.71
Neurocrine Biosciences (NBIX) United States $14.958B 35.89
Shionogi (SGIOY) Japan $14.547B 13.36
Summit Therapeutics (SMMT) United States $14.112B 0.00
IPSEN (IPSEY) France $12.438B 0.00
Ionis Pharmaceuticals (IONS) United States $11.264B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.262B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.283B 0.00
Corcept Therapeutics (CORT) United States $7.941B 85.78
Stevanato Group S.p.A (STVN) Italy $7.344B 41.10
Grifols, S.A (GRFS) Spain $5.913B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.389B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.606B 17.13
Centessa Pharmaceuticals (CNTA) United Kingdom $2.990B 0.00
Hypermarcas (HYPMY) Brazil $2.983B 22.43
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.650B 8.45
Dyne Therapeutics (DYN) United States $2.644B 0.00
Soleno Therapeutics (SLNO) United States $2.487B 0.00
Ocular Therapeutix (OCUL) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.963B 23.27
Guardian Pharmacy Services (GRDN) United States $1.884B 36.28
Avadel Pharmaceuticals (AVDL) Ireland $1.816B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.516B 90.00
Collegium Pharmaceutical (COLL) United States $1.376B 6.81
Ardelyx (ARDX) United States $1.373B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.338B 0.00
Xeris Biopharma Holdings (XERS) United States $1.281B 0.00
Harrow (HROW) United States $1.263B 77.59
Nektar Therapeutics (NKTR) United States $1.179B 0.00
Oruka Therapeutics (ORKA) United States $1.161B 0.00
Enliven Therapeutics (ELVN) United States $1.108B 0.00
Relay Therapeutics (RLAY) United States $1.069B 0.00
Evotec AG (EVO) Germany $1.062B 0.00
Xencor (XNCR) United States $0.981B 0.00
Cronos Group (CRON) Canada $0.980B 0.00
ARS Pharmaceuticals (SPRY) United States $0.878B 0.00
Organogenesis (ORGO) United States $0.830B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.759B 32.08
Savara (SVRA) United States $0.691B 0.00
Esperion Therapeutics (ESPR) United States $0.689B 0.00
Aquestive Therapeutics (AQST) United States $0.681B 0.00
Elite Pharmaceuticals (ELTP) United States $0.680B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.627B 5.60
Bioventus (BVS) United States $0.619B 12.69
KalVista Pharmaceuticals (KALV) United States $0.550B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
4D Molecular Therapeutics (FDMT) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.466B 6.38
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Altimmune (ALT) United States $0.445B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.411B 9.73
USANA Health Sciences (USNA) United States $0.351B 9.79
Nature's Sunshine Products (NATR) United States $0.346B 20.60
Lyell Immunopharma (LYEL) United States $0.340B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Korro Bio (KRRO) United States $0.306B 0.00
Pyxis Oncology (PYXS) United States $0.297B 0.00
Larimar Therapeutics (LRMR) United States $0.294B 0.00
Achieve Life Sciences (ACHV) Canada $0.237B 0.00
Journey Medical (DERM) United States $0.235B 0.00
Aclaris Therapeutics (ACRS) United States $0.231B 0.00
OmniAb (OABI) United States $0.214B 0.00
AleAnna (ANNA) United States $0.214B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Avalo Therapeutics (AVTX) United States $0.200B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Protara Therapeutics (TARA) United States $0.175B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.165B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.148B 0.00
Cassava Sciences (SAVA) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.126B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.118B 0.00
Context Therapeutics (CNTX) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.104B 0.00
Surrozen (SRZN) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.093B 33.90
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Gain Therapeutics (GANX) United States $0.090B 0.00
Unicycive Therapeutics (UNCY) United States $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Lite Strategy (LITS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.077B 0.00
Plus Therapeutics (PSTV) United States $0.077B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Prelude Therapeutics (PRLD) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Rafael Holdings (RFL) United States $0.067B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
PolyPid (PYPD) Israel $0.059B 0.00
Talphera (TLPH) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.056B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Jupiter Neurosciences (JUNS) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
Inotiv (NOTV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.030B 24.75
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Mangoceuticals (MGRX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Heatwurx (PCSA) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Ainos (AIMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.76
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00